Supplementary Table 3. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
收藏DataCite Commons2024-05-16 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Supplementary_Table_3_Real-world_data_on_treatment_outcomes_in_EGFR-mutant_non-small-cell_lung_cancer_patients_receiving_osimertinib_in_second_or_further_lines/14595807
下载链接
链接失效反馈官方服务：
资源简介：
<b>Supplementary Table 3</b>.
Real world data on treatment outcomes in EGFR mutant NSCLC patients receiving
osimertinib in second or further lines
Cox regression univariate
and multivariate analysis including all covariates potentially impacting on
overall survival.<sup></sup>
提供机构：
Taylor & Francis
创建时间：
2021-05-14
